X T L Biopharmaceuticals reported $-812K in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Bioline Rx USD -2.21M 96K Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
X T L Biopharmaceuticals USD -812K 48K Dec/2024